These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1360411

  • 21. Liberators of NO exert a dual effect on renin secretion from isolated mouse renal juxtaglomerular cells.
    Schricker K, Kurtz A.
    Am J Physiol; 1993 Aug; 265(2 Pt 2):F180-6. PubMed ID: 8396340
    [Abstract] [Full Text] [Related]

  • 22. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
    Gerzer R, Karrenbrock B, Siess W, Heim JM.
    Thromb Res; 1988 Oct 01; 52(1):11-21. PubMed ID: 2904706
    [Abstract] [Full Text] [Related]

  • 23. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
    Ijioma SC, Challiss RA, Boyle JP.
    Br J Pharmacol; 1995 Jul 01; 115(5):723-32. PubMed ID: 8548169
    [Abstract] [Full Text] [Related]

  • 24. Nitric oxide donors inhibit spontaneous depolarizations by L-type Ca2+ currents in alveolar epithelial cells.
    Schobersberger W, Friedrich F, Hoffmann G, Völkl H, Dietl P.
    Am J Physiol; 1997 Jun 01; 272(6 Pt 1):L1092-7. PubMed ID: 9227509
    [Abstract] [Full Text] [Related]

  • 25. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure.
    Gupta G, Azam M, Yang L, Danziger RS.
    J Clin Invest; 1997 Sep 15; 100(6):1488-92. PubMed ID: 9294115
    [Abstract] [Full Text] [Related]

  • 26. Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors.
    Musialek P, Rigg L, Terrar DA, Paterson DJ, Casadei B.
    J Mol Cell Cardiol; 2000 Oct 15; 32(10):1831-40. PubMed ID: 11013127
    [Abstract] [Full Text] [Related]

  • 27. Effect of intracerebroventricular and intravenous administration of nitric oxide donors on blood pressure and heart rate in anaesthetized rats.
    Nurminen ML, Vapaatalo H.
    Br J Pharmacol; 1996 Dec 15; 119(7):1422-6. PubMed ID: 8968551
    [Abstract] [Full Text] [Related]

  • 28. Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries.
    Kukovetz WR, Holzmann S.
    J Cardiovasc Pharmacol; 1989 Dec 15; 14 Suppl 11():S40-6. PubMed ID: 2484698
    [Abstract] [Full Text] [Related]

  • 29. Exogenous nitric oxide inhibits VCAM-1 expression in human peritoneal mesothelial cells. Role of cyclic GMP and NF-kappaB.
    Lee SK, Kim JH, Yang WS, Kim SB, Park SK, Park JS.
    Nephron; 2002 Apr 15; 90(4):447-54. PubMed ID: 11961404
    [Abstract] [Full Text] [Related]

  • 30. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.
    Schröder H, Ney P, Woditsch I, Schrör K.
    Eur J Pharmacol; 1990 Jul 03; 182(2):211-8. PubMed ID: 1697805
    [Abstract] [Full Text] [Related]

  • 31. Effects of SIN-1 on isolated canine basilar arteries.
    Katusic ZS, Vanhoutte PM.
    J Cardiovasc Pharmacol; 1989 Jul 03; 14 Suppl 11():S72-5. PubMed ID: 2484704
    [Abstract] [Full Text] [Related]

  • 32. Nitric oxide stimulates cyclic GMP in human thyrocytes.
    Millatt LJ, Jackson R, Williams BC, Whitley GS.
    J Mol Endocrinol; 1993 Apr 03; 10(2):163-9. PubMed ID: 8097915
    [Abstract] [Full Text] [Related]

  • 33. Evidence for the involvement of cGMP in neural bronchodilator responses in humal trachea.
    Ward JK, Barnes PJ, Tadjkarimi S, Yacoub MH, Belvisi MG.
    J Physiol; 1995 Mar 01; 483 ( Pt 2)(Pt 2):525-36. PubMed ID: 7650619
    [Abstract] [Full Text] [Related]

  • 34. Co-operation between particulate and soluble guanylyl cyclase systems in the rat renal glomeruli.
    Stepinski J, Wendt U, Lewko B, Angielski S.
    J Physiol Pharmacol; 2000 Sep 01; 51(3):497-511. PubMed ID: 11016869
    [Abstract] [Full Text] [Related]

  • 35. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
    Hwang TL, Wu CC, Teng CM.
    Br J Pharmacol; 1998 Nov 01; 125(6):1158-63. PubMed ID: 9863642
    [Abstract] [Full Text] [Related]

  • 36. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J, Zabel U, Hübner U, Hatzelmann A, Wagner B, Wanner C, Schmidt HH.
    Br J Pharmacol; 1999 May 01; 127(1):195-203. PubMed ID: 10369473
    [Abstract] [Full Text] [Related]

  • 37. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
    Toque HA, Mónica FZ, Morganti RP, De Nucci G, Antunes E.
    Eur J Pharmacol; 2010 Oct 25; 645(1-3):158-64. PubMed ID: 20670622
    [Abstract] [Full Text] [Related]

  • 38. Role of anions in nitric oxide-induced short-circuit current increase in isolated porcine ciliary processes.
    Wu R, Yao K, Flammer J, Haefliger IO.
    Invest Ophthalmol Vis Sci; 2004 Sep 25; 45(9):3213-22. PubMed ID: 15326143
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y, Karmazyn M.
    Cardiovasc Res; 1996 Sep 25; 32(3):622-9. PubMed ID: 8881523
    [Abstract] [Full Text] [Related]

  • 40. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
    Bult H, Fret HR, Herman AG.
    J Cardiovasc Pharmacol; 1989 Sep 25; 14 Suppl 11():S120-3. PubMed ID: 2484689
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.